Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gerard Criner, MD
Temple University School of Medicine, 3401 North Broad Street, Suite 745 PP, Philadelphia, PA 19140
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
343 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Buenos Aires, Argentina
- Research Site
CABA, Argentina
- Research Site
Ciudad Autónoma de Buenos Aire, Argentina
- Research Site
Ciudad de Buenos Aires, Argentina
- Research Site
Córdoba, Argentina
- Research Site
Florida, Argentina
- Research Site
Mar del Plata, Argentina
- Research Site
Mendoza, Argentina
- Research Site
San Fernando, Argentina
- Research Site
San Juan Bautista, Argentina
- Research Site
San Miguel de Tucumán, Argentina
- Research Site
Caringbah, Australia
- Research Site
Melbourne, Australia
- Research Site
South Brisbane, Australia
- Research Site
Southport, Australia
- Research Site
Spearwood, Australia
- Research Site
Bad Ischl, Austria
- Research Site
Bludenz, Austria
- Research Site
Feldbach, Austria
- Research Site
Grieskirchen, Austria
- Research Site
Linz, Austria
- Research Site
Thalheim, Austria
- Research Site
Edegem, Belgium
- Research Site
Erpent, Belgium
- Research Site
Blumenau, Brazil
- Research Site
Botucatu, Brazil
- Research Site
Florianópolis, Brazil
- Research Site
Maringá, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Santo André, Brazil
- Research Site
Sorocaba, Brazil
- Research Site
São Bernardo do Campo, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Kozloduy, Bulgaria
- Research Site
Rousse, Bulgaria
- Research Site
Stara Zagora, Bulgaria
- Research Site
Calgary, Alberta, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Aug 2019
- Primary completion
- 28 Jul 2025
- Completion
- 28 Jul 2025
- Last update posted
- 19 Aug 2025
- Registered enrollment
- 689
- Registry id
- NCT04053634
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.